Authors: Kuttner-Kondo, LA Mitchell, L Hourcade, DE Medof, ME

Citation: La. Kuttner-kondo et al., Characterization of the active sites in decay-accelerating factor, J IMMUNOL, 167(4), 2001, pp. 2164-2171

Authors: Moulds, JM Zimmerman, PA Doumbo, OK Kassambara, L Sagara, I Diallo, DA Atkinson, JP Krych-Goldberg, M Hauhart, RE Hourcade, DE McNamara, DT Birmingham, DJ Rowe, JA Moulds, JJ Miller, LH

Citation: Jm. Moulds et al., Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1, BLOOD, 97(9), 2001, pp. 2879-2885

Authors: Hourcade, DE Mitchell, LM Medof, ME

Citation: De. Hourcade et al., Decay acceleration of the complement alternative pathway C3 convertase, IMMUNOPHARM, 42(1-3), 1999, pp. 167-173

Authors: Hourcade, DE Mitchell, LM Oglesby, TJ

Citation: De. Hourcade et al., Mutation of the type A domain of complement factor B that promote high-affinity C3b-binding, J IMMUNOL, 162(5), 1999, pp. 2906-2911

Authors: Krych-Goldberg, M Hauhart, RE Subramanian, VB Yurcisin, BM Crimmins, DL Hourcade, DE Atkinson, JP

Citation: M. Krych-goldberg et al., Decay accelerating activity of complement receptor type 1 (CD35) - Two active sites are required for dissociating C5 convertases, J BIOL CHEM, 274(44), 1999, pp. 31160-31168